2022-05-24-世界经济论坛-Urgent,_Coordinated_Global_Action_on_Lung_Cancer_22页_1mb

Urgent, Coordinated Global Action on Lung Cancer

The Lung Ambition Alliance, in partnership with the World Economic Forum, has released this white paper to address the critical challenge of lung cancer on the global stage. Lung cancer is a leading cause of cancer deaths, with 2.2 million new cases per year, projected to increase by 30% (to over 2.3 million cases) by 2030 if no global action is taken, potentially falling short of Sustainable Development Goal (SDG) 3.4 target to reduce premature mortality from non-communicable diseases by one-third by 2030. Current inaction risks increased mortality, exacerbated by COVID-19 disruptions that have delayed diagnosis and care.

Key findings include the high prevalence and impact of lung cancer, especially in low and middle-income countries, with poor survival rates (e.g., under 20% five-year survival in many regions). Early detection, when feasible (e.g., screening for high-risk groups like ex-smokers), can dramatically improve survival rates (68%-92% for stage one) and reduce healthcare costs. Investment in tobacco control and supportive care is also essential.

Recommendations

• Overarching: Countries should integrate early detection and treatment into national cancer control plans to meet global health goals.
• Early Detection and Screening: Implement targeted screening programs using low-dose computed tomography (LDCT) in high-risk populations, remove barriers like access and awareness, and leverage technologies such as AI to enhance diagnosis and reach underserved groups.
• Quality of Care: Shorten diagnostic pathways, adopt multidisciplinary teams for coordinated care, and improve patient-centered approaches to support timely, effective treatment.
• Finance and Infrastructure: Prioritize investments through cost-benefit analysis, explore innovative funding models (e.g., social impact bonds), and increase tobacco-related taxes to fund lung cancer interventions.

Urgent, coordinated global collaboration is necessary to reduce lung cancer mortality and unlock significant economic, social, and health benefits.